The collaborators hope initial research in canines can be a proving ground for synthetic viruses designed to kill particular tumors, perhaps even in humans.
Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.
In Science this week: effort to reduce E. coli genome, and more.
A new study in Scientific Reports describes how scientists were able to replace an entire gene in a bacterial genome to study its function.
The Scientist traces the career path of the J. Craig Venter Institute's Clyde Hutchinson.
The researchers identified new combinations of mutated genes and drugs that could provide the platform for future cancer therapies.
Researchers and business leaders unveil their plan for HGP-write to synthesize full genomes.
A proposal published in Science lays out a vision to drive down the cost of fabricating genomes and accelerate research and innovation in synthetic biology.
Harvard's George Church says that a project to create synthetic human genomes at the center of last week's controversial meeting is at the 'thought experiment' stage.
Researchers have developed a programming language to design computational circuits for living cells.
In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.
Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.
The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.
Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.